Suppr超能文献

13价肺炎球菌结合疫苗引入后儿童侵袭性肺炎球菌疾病的早期趋势:墨西哥一家医院八年主动监测结果

Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital.

作者信息

Chacon-Cruz Enrigue, Rivas-Landeros R M, Volker-Soberanes M L

机构信息

Pediatric Infectious Diseases Service, Hospital General de Tijuana, Tijuana Baja-California, Paseo Centenario S/N, Zona Rio, Tijuana, Baja-California, ZC 22010, Mexico.

Microbiology Laboratory, Hospital General de Tijuana, Tijuana Baja-California, Mexico.

出版信息

Ther Adv Vaccines. 2014 Nov;2(6):155-8. doi: 10.1177/2051013614547199.

Abstract

BACKGROUND

In May 2012, universal vaccination with the 13-valent pneumococcal conjugate vaccine (PCV-13) was introduced for all children in the Tijuana region of Mexico, with a coverage of 80%.

METHOD

Between October 2005 and September 2013 active surveillance was undertaken for all invasive pneumococcal diseases (IPDs) in children admitted to the Tijuana General Hospital.

RESULTS

Following PCV-13 implementation, there was a 75% reduction in overall IPD, and no cases of serotype 19A, pneumococcal meningitis, and pneumococcal-associated deaths.

CONCLUSIONS

These results are the first to show the effectiveness of PCV-13 in Mexico.

摘要

背景

2012年5月,墨西哥蒂华纳地区所有儿童开始普遍接种13价肺炎球菌结合疫苗(PCV-13),接种率为80%。

方法

2005年10月至2013年9月,对蒂华纳总医院收治的儿童所有侵袭性肺炎球菌疾病(IPD)进行了主动监测。

结果

实施PCV-13疫苗接种后,总体IPD减少了75%,且未出现19A血清型、肺炎球菌脑膜炎及肺炎球菌相关死亡病例。

结论

这些结果首次表明PCV-13在墨西哥的有效性。

相似文献

引用本文的文献

6
Epidemiology, virulence factors and management of the pneumococcus.肺炎球菌的流行病学、毒力因子与管理
F1000Res. 2016 Sep 14;5:2320. doi: 10.12688/f1000research.9283.1. eCollection 2016.

本文引用的文献

6
Pneumococcal vaccines for children: a global public health priority.儿童肺炎球菌疫苗:全球公共卫生重点。
Clin Microbiol Infect. 2012 Oct;18 Suppl 5:25-36. doi: 10.1111/j.1469-0691.2012.03938.x. Epub 2012 Aug 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验